Browsing Category
Biotech
London Based Obesity Drug Innovator Secures Record Breaking $411 Million Dollar Investment Round
A groundbreaking series A funding round has positioned London-based Verdiva Bio at the forefront of the obesity treatment sector, securing an impressive $411 million investment. This remarkable achievement stands as Europe's largest…
GSK Set to Acquire US Biotechnology Company IDRx in $1 Billion Dollar Deal
British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with the upcoming JP Morgan…
UK Biotech Pioneer Aucatzyl Takes Bold Step in Cancer Treatment Revolution
A groundbreaking personalised cancer treatment is emerging from an unexpected location: Stevenage High Street. UK biotech firm Autolus has received FDA approval to manufacture and distribute its innovative Car-T cell therapy, Aucatzyl,…
Big Pharma Deals Hit Nine Year Low as Industry Shifts Focus
The pharmaceutical industry has witnessed a dramatic decline in deal activity, reaching its lowest point in nearly a decade as major drugmakers pivot away from commercially ready medicines towards early-stage drug development investments.…
AbbVie Stock Plunges as Key Schizophrenia Drug Trial Falls Short
Pharmaceutical giant AbbVie witnessed a devastating blow to its market value today as shares plummeted following disappointing clinical trial results for its experimental schizophrenia treatment, Emraclidine.
The Chicago-based…
Revolutionary Weight Loss Jabs Have The Potential To Treat Cancer, Arthritis, Alzheimer’s, and…
The pharmaceutical industry stands on the cusp of a major transformation as revolutionary weight-loss injections demonstrate potential far beyond their initial scope. Semaglutide, marketed under brands like Ozempic and Wegovy, has shown…
Groundbreaking mRNA Lung Cancer Vaccine Trials Commence Across Seven Nations
In a significant development in the fight against lung cancer, doctors have initiated the world's first mRNA lung cancer vaccine trials in patients across seven countries. This pioneering jab, known as BNT116 and developed by BioNTech, has…
Brain Implants Poised to Revolutionise Treatment for Epilepsy and Other Conditions
In a groundbreaking development, brain implants are emerging as a potential game-changer in the treatment of various neurological and chronic conditions. Startups across the globe are engaging in clinical trials to explore the possibilities…
The next big investment boom could be lab-grown food – which will save the planet.
Solar power 20 years ago was cellular agriculture, and EV battery 10 years earlier.
Moore's Law has a rapid impact on costs, reducing them from high levels to a level closer to "griddle-parity". As investors tire of AI's boom, it is…